Since its release in 1985, Margaret Atwood’s The Handmaid’s Tale novel has been banned in several countries, including the United States and Canada.

We developed ways to communicate in a secret and coded language because we had to.” In the nineteen-sixties and seventies, cruising spots were listed in printed directories, such as Bob Damron’s “ ...

Consumer prices rose 2.7% in June from a year earlier, the Labor Department said Tuesday, up from an annual increase of 2.4% ...

During Friday’s Morrow County Chamber of Commerce ribbon-cutting ceremonies, downtown shoppers were delighted with the ...

While the characters on "The Handmaid's Tale" don't get to be glamorous, their portrayals know how to turn up the sparkle on the red carpet.

Gilead has blamed the low rate of respiratory syncytial virus infections last season for ending two midstage trials of obeldesivir.

We came across a bullish thesis on Vericel Corporation on R.Dennis’s Substack by OppCost. In this article, we will summarize ...

Shares of Gilead rose 3% after the U.S. Supreme Court on Friday upheld a federal mandate that requires health insurers to cover preventive care services including those for reducing HIV risk and ...

A HIV physician expects a “majority” of her 125 PrEP users will switch to Gilead's newly approved Yeztugo within the next 12 months.

Gilead Sciences partners with Kymera Therapeutics to develop cancer drugs, with Kymera eligible for up to $750M & royalties. Read more here.

Kymera signs $750 million CDK2 drug deal with Gilead and earns $20 million from Sanofi as KT-485 advances toward clinical trials in inflammatory diseases.

Gilead Sciences, Inc. (NASDAQ: GILD) and Kymera Therapeutics, Inc. (NASDAQ: KYMR), today announced that they have entered into an exclusive option and license agreement to accelerate the ...